Canada
Canada
Explore linked clinical trials.448 results · Page 1 of 18
Cities
Swipe the table sideways for more columns.
| Cities | City | Country | Linked trials |
|---|---|---|---|
| Abbotsford British Columbia | Abbotsford British Columbia | Canada | 3 |
| Abbotsford British Columbia | Abbotsford British Columbia | Canada | 32 |
| Airdrie | Airdrie | Canada | 1 |
| Ajax | Ajax | Canada | 6 |
| Ajax | Ajax | Canada | 57 |
| Alberta | Alberta | Canada | 2 |
| Alliston | Alliston | Canada | 1 |
| Antigonish Nova Scotia | Antigonish Nova Scotia | Canada | 1 |
| Arviat | Arviat | Canada | 1 |
| Aurora | Aurora | Canada | 1 |
| Aylmer | Aylmer | Canada | 1 |
| Baie-Saint-Paul | Baie-Saint-Paul | Canada | 1 |
| Banff | Banff | Canada | 2 |
| Barrie | Barrie | Canada | 5 |
| Barrie | Barrie | Canada | 127 |
| Bathurst | Bathurst | Canada | 1 |
| Bedford | Bedford | Canada | 2 |
| Belleville | Belleville | Canada | 2 |
| Blenheim | Blenheim | Canada | 1 |
| Boisbriand | Boisbriand | Canada | 4 |
| Bouctouche | Bouctouche | Canada | 1 |
| Bowmanville | Bowmanville | Canada | 1 |
| Brampton | Brampton | Canada | 22 |
| Brampton | Brampton | Canada | 132 |
| Brandon | Brandon | Canada | 6 |
6,531 results · Page 1 of 262
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Advancing Health Equity and Preventive Cardiovascular Care in Indigenous and Remote Communities: a Mobile Healthcare Unit | Nutritional and Metabolic Diseases, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Recruiting | Not applicable | 2026-10-09 | NCT07869069 | |
| Objective Depth-of-Focus Changes During Light Adjustable Lens UV Adjustments | Light Adjustable Lens; Objective Depth of Focus | Not yet recruiting | Not stated | 2026-10-09 | NCT07868003 | |
| Memantine Targeting Neurovascular Dysfunction After Mild and Moderate Traumatic Brain Injury (MEND) | Brain Concussion, Brain Injuries, Traumatic, Concussion, Mild, Craniocerebral Trauma, Head Injuries, Closed, Wounds, Nonpenetrating, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury | Not yet recruiting | Phase 2 | 2026-10-09 | NCT07867210 | |
| Patient Experiences of Intraoperative Discomfort During Cesarean Delivery Under Neuraxial Anesthesia | Discomfort; Psychological Well Being | Recruiting | Not stated | 2026-10-09 | NCT07867106 | |
| Ivabradine for Heart Rate Reduction During Exercise in Healthy Adults | Healthy Adult | Recruiting | Early phase 1 | 2026-10-09 | NCT07717710 | |
| A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 2 | 2026-10-09 | NCT07644559 | |
| Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer | Advanced HR+/HER2- Breast Cancer | Recruiting | Phase 1 | 2026-10-09 | NCT07604571 | |
| Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed) | brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, transient ischemic attack, vascular disorder | Recruiting | Not applicable | 2026-10-09 | NCT07576647 | |
| A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Not stated | 2026-10-09 | NCT07556159 | |
| A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) | Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Recruiting | Phase 2 | 2026-10-09 | NCT07533006 | |
| A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-10-09 | NCT07513376 | |
| Cervicothoracic Sympathetic Block Evaluation for Post COVID Condition | autonomic nervous system disorder, nervous system disorder, primary dysautonomia | Recruiting | Phase 4 | 2026-10-09 | NCT07468604 | |
| Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07468071 | |
| A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 3 | 2026-10-09 | NCT07463521 | |
| Study of INCA036978 in Participants With Myeloproliferative Neoplasms | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, acquired polycythemia vera, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, neoplasm, primary myelofibrosis, thrombocytosis disease | Recruiting | Phase 1 | 2026-10-09 | NCT07441694 | |
| A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies | Solid Tumors | Recruiting | Phase 2 | 2026-10-09 | NCT07415031 | |
| A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Recruiting | Phase 3 | 2026-10-09 | NCT07357727 | |
| The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes | Feeding and Eating Disorders, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, psychiatric disorder, type 1 diabetes mellitus | Recruiting | Not stated | 2026-10-09 | NCT07348432 | |
| Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 2 | 2026-10-09 | NCT07341282 | |
| Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study | Acute Hypoxemic Respiratory Failure, Respiration Disorders, respiratory failure, respiratory system disorder | Recruiting | Phase 2 | 2026-10-09 | NCT07334379 | |
| Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, skin disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07288359 | |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 3 | 2026-10-09 | NCT07284849 | |
| Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Recruiting | Phase 2 | 2026-10-09 | NCT07284459 | |
| A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 2 | 2026-10-09 | NCT07276581 | |
| Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, pancreatic ductal adenocarcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 1 | 2026-10-09 | NCT07261631 |